The PI3K inhibitor GDC-0941 combines with existing clinical...

Oncogene 2014 / 01 Vol. 33; Iss. 3

The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma

Munugalavadla, V, Mariathasan, S, Slaga, D, Du, C, Berry, L, Del Rosario, G, Yan, Y, Boe, M, Sun, L, Friedman, L S, Chesi, M, Leif Bergsagel, P, Ebens, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Oncogene
DOI:
10.1038/onc.2012.594
Date:
January, 2014
File:
PDF, 1.84 MB
english, 2014
Conversion to is in progress
Conversion to is failed